ACCESSION: MSBNK-SMB_Measured-HSA001P0208003
RECORD_TITLE: Uncharacterized; LC-ESI-QFT; MS2; POSITIVE; Averaged data
DATE: 2025.04.02 (Averaged 2025.02.17, Processed 2025.02.17, Annotated 2025.03.05, Curated 2025.04.02)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Shin-MassBank project in preparation
COMMENT: This is an averaged mass spectra data created by averaging product ion scan data obtained from the following DDA dataset.
COMMENT: REPOSITORY MB-POST
COMMENT: DATASET_ID MPST000004
COMMENT: DATASET_TITLE Annotation of various metabolites in SRM 1950 human serum
COMMENT: DATASET_AUTHORS Masatomo Takahashi, Yoshihiro Izumi, Kyoshu University
COMMENT: MS1_M/Z_AVERAGED_THRES 0.750
COMMENT: MS2_M/Z_AVERAGED_THRES 4.000
COMMENT: DATASET_FILE_NUM 22
COMMENT: NUM_AVERAGED_SPEC 31
COMMENT: RAW_SPEC {'BLK02_1521': {'bp': 344578.0, 'sum': 586895.0}, '14_posi_1546': {'bp': 230389.0, 'sum': 400005.0}, '9_posi_1523': {'bp': 241156.0, 'sum': 418784.0}, '8_posi_1544': {'bp': 271376.0, 'sum': 463765.0}, '8_posi_1608': {'bp': 242838.0, 'sum': 462017.0}, '15_posi_1586': {'bp': 204774.0, 'sum': 408348.0}, '3_posi_1606': {'bp': 251545.0, 'sum': 483001.0}, '6_posi_1609': {'bp': 230795.0, 'sum': 422631.0}, '9_posi_1607': {'bp': 244738.0, 'sum': 430631.0}, '6_posi_1544': {'bp': 231613.0, 'sum': 446762.0}, '12_posi_1502': {'bp': 230730.0, 'sum': 422958.0}, '13_posi_1500': {'bp': 247880.0, 'sum': 434915.0}, '2_posi_1587': {'bp': 283618.0, 'sum': 498037.0}, '5_posi_1523': {'bp': 235138.0, 'sum': 419112.0}, '4_posi_1502': {'bp': 223785.0, 'sum': 404069.0}, '3_posi_1543': {'bp': 262010.0, 'sum': 491818.0}, '16_posi_1586': {'bp': 254292.0, 'sum': 432318.0}, '16_posi_1522': {'bp': 251537.0, 'sum': 435945.0}, '10_posi_1584': {'bp': 240467.0, 'sum': 421793.0}, '7_posi_1545': {'bp': 238749.0, 'sum': 430332.0}, 'BLK02_1583': {'bp': 338104.0, 'sum': 603323.0}, 'ProcedureBlank_1583': {'bp': 286360.0, 'sum': 505447.0}, '4_posi_1605': {'bp': 236384.0, 'sum': 453268.0}, '13_posi_1608': {'bp': 218782.0, 'sum': 434682.0}, '1_posi_1542': {'bp': 285759.0, 'sum': 518381.0}, '11_posi_1584': {'bp': 251663.0, 'sum': 443628.0}, '11_posi_1503': {'bp': 239967.0, 'sum': 454802.0}, '5_posi_1586': {'bp': 267757.0, 'sum': 459980.0}, '1_posi_1604': {'bp': 253547.0, 'sum': 456563.0}, '10_posi_1502': {'bp': 246386.0, 'sum': 450622.0}, '2_posi_1523': {'bp': 313658.0, 'sum': 513809.0}}
COMMENT: RETENTION_TIME_STDEV 0.078
COMMENT: PRECURSOR_M/Z_RAW 208.155334
COMMENT: PRECURSOR_M/Z_STDEV 0.000061
COMMENT: PRECURSOR_IN_MS1 mz 208.155684; int 35.689; delta(ppm) 1.015804
COMMENT: PROPOSED_CHARGE_STATE ND
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_ION_FORM M+H; M+CH3OH+H; mz 240.181843; int 20.525; cor 0.621
COMMENT: PROPOSED_ION_FORM M+ACN+H; M+CH3OH+H; mz 199.155357; int 52.235; cor 0.640
COMMENT: PROPOSED_ION_FORM M+2ACN+H; M+H; mz 126.102588; int 768.537; cor 0.615
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 0.077; C10H17N5; [M+H]+; delta(ppm) 0.077239
COMMENT: PROPOSED_MF SevenGoldenRules 0.114; C8H14N4; [M+ACN+H]+; delta(ppm) 0.114374
COMMENT: PROPOSED_MF SevenGoldenRules 0.168; C6H11N3; [M+2ACN+H]+; delta(ppm) 0.167872
COMMENT: PROPOSED_MF MS-FINDER 3.485; C6H11N3; [M+2ACN+H]+; delta(ppm) 368494.142024
COMMENT: PROPOSED_MF MS-FINDER 3.124; C8H14N4; [M+ACN+H]+; delta(ppm) 77788.640757
COMMENT: PROPOSED_MF MS-FINDER 2.802; C10H17N5; [M+H]+; delta(ppm) 0.076812
COMMENT: PROPOSED_MF SIRIUS5_Sirius 5.116; C8H14N4; [M+C2H3N+H]+; delta(ppm) 0.076812
COMMENT: PROPOSED_MF SIRIUS5_Sirius 5.116; C10H17N5; [M+H]+; delta(ppm) 0.076812
COMMENT: PROPOSED_MF SIRIUS5_Sirius 3.083; C6H11N3; [M+C4H6N2+H]+; delta(ppm) 0.076812
COMMENT: PROPOSED_MF SIRIUS5_Sirius 2.163; C9H21NO4; [M+H]+; delta(ppm) 6.501920
COMMENT: PROPOSED_MF SIRIUS5_Sirius -4.254; C10H16NO; [M+C2H3N+H]+; delta(ppm) -6.373433
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 1.000; C8H14N4; [M+C2H3N+H]+; delta(ppm) 0.076812
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 1.000; C6H11N3; [M+C4H6N2+H]+; delta(ppm) 0.076812
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 1.000; C10H17N5; [M+H]+; delta(ppm) 0.076812
COMMENT: PROPOSED_MF SIRIUS6_Sirius 16.246; C8H14N4; [M+C2H3N+H]+; delta(ppm) 0.076812
COMMENT: PROPOSED_MF SIRIUS6_Sirius 16.246; C10H17N5; [M+H]+; delta(ppm) 0.076812
COMMENT: PROPOSED_MF SIRIUS6_Sirius 16.246; C6H11N3; [M+C4H6N2+H]+; delta(ppm) 0.076812
COMMENT: PROPOSED_MF SIRIUS6_Sirius 11.184; C5H15FN4O; [M+C2H3N+H]+; delta(ppm) -5.412579
COMMENT: PROPOSED_MF SIRIUS6_Sirius 11.184; C7H18FN5O; [M+H]+; delta(ppm) -5.412579
COMMENT: PROPOSED_MF SIRIUS6_Sirius 4.773; C10H16NO; [M+C2H3N+H]+; delta(ppm) -6.373433
COMMENT: PROPOSED_MF SIRIUS6_Sirius 4.773; C12H19N2O; [M+H]+; delta(ppm) -6.373433
COMMENT: PROPOSED_MF SIRIUS6_Sirius 4.773; C8H13O; [M+C4H6N2+H]+; delta(ppm) -6.373433
COMMENT: PROPOSED_MF SIRIUS6_Sirius 3.153; C9H22ClN3; [M+H]+; delta(ppm) -103385.907985
COMMENT: PROPOSED_MF SIRIUS6_Sirius 3.115; C9H21NO4; [M+H]+; delta(ppm) 6.501920
COMMENT: PROPOSED_MF SIRIUS6_Sirius 0.107; C8H22N3OP; [M+H]+; delta(ppm) -7.858373
COMMENT: PROPOSED_MF SIRIUS6_Sirius -5.759; C4H17N5P; [M+C2H3N+H]+; delta(ppm) -1.408147
COMMENT: PROPOSED_MF SIRIUS6_Sirius -5.759; C6H20N6P; [M+H]+; delta(ppm) -1.408147
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C8H14N4; [M+C2H3N+H]+; delta(ppm) 0.076812
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C10H17N5; [M+H]+; delta(ppm) 0.076812
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C6H11N3; [M+C4H6N2+H]+; delta(ppm) 0.076812
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.949; FHQDWPCFSJMNCT-UHFFFAOYSA-N; [M+2ACN+H]+; 1-Methylhistamine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.637; CPAGZVLINCPJEH-UHFFFAOYSA-N; [M+2ACN+H]+; 3-Methylhistamine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.456; PHSPJQZRQAJPPF-UHFFFAOYSA-N; [M+2ACN+H]+; N-Methylhistamine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.456; KDHWOCLBMVSZPG-UHFFFAOYSA-N; [M+2ACN+H]+; 1H-imidazole-1-propylamine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.411; UGYXPZQILZRKJJ-UHFFFAOYSA-N; [M+2ACN+H]+; 4-methylhistamine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.411; XDKYTXBAVJELDQ-UHFFFAOYSA-N; [M+2ACN+H]+; 2-methylhistamine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.411; XNQIOISZPFVUFG-RXMQYKEDSA-N; [M+2ACN+H]+; (R)-alpha-methylhistamine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.213; LNWMKFPGICKEQH-UHFFFAOYSA-N; [M+2ACN+H]+; (1-methyl-2,3-dihydropyridin-6-ylidene)hydrazine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.893; RHRVANRKEISTIR-UHFFFAOYSA-N; [M+ACN+H]+; 3,3'-(ethylenediimino)bispropiononitrile
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; RHRVANRKEISTIR-UHFFFAOYSA-N; [M+ACN+H]+; 3,3'-(ethylenediimino)bispropiononitrile
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; FHQDWPCFSJMNCT-UHFFFAOYSA-N; [M+2ACN+H]+; 1-Methylhistamine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.993; UGYXPZQILZRKJJ-UHFFFAOYSA-N; [M+2ACN+H]+; 4-methylhistamine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.993; XDKYTXBAVJELDQ-UHFFFAOYSA-N; [M+2ACN+H]+; 2-methylhistamine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.986; CPAGZVLINCPJEH-UHFFFAOYSA-N; [M+2ACN+H]+; 3-Methylhistamine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.925; KDHWOCLBMVSZPG-UHFFFAOYSA-N; [M+2ACN+H]+; 1H-imidazole-1-propylamine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.901; PHSPJQZRQAJPPF-UHFFFAOYSA-N; [M+2ACN+H]+; N-Methylhistamine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.901; XNQIOISZPFVUFG-RXMQYKEDSA-N; [M+2ACN+H]+; (R)-alpha-methylhistamine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.385; LNWMKFPGICKEQH-UHFFFAOYSA-N; [M+2ACN+H]+; (1-methyl-2,3-dihydropyridin-6-ylidene)hydrazine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.966; QSERFXPZIOTLLW-UHFFFAOYSA-N; [M+H]+; N,N-dimethyl-4-piperazin-1-ylpyrimidin-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.872; RHRVANRKEISTIR-UHFFFAOYSA-N; [M+ACN+H]+; 3-[2-(2-cyanoethylamino)ethylamino]propanenitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.767; XNQIOISZPFVUFG-UHFFFAOYSA-N; [M+2ACN+H]+; 1-(1H-imidazol-5-yl)propan-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.650; FHQDWPCFSJMNCT-UHFFFAOYSA-N; [M+2ACN+H]+; 2-(1-methylimidazol-4-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.392; NIPMIDGUMALDHC-UHFFFAOYSA-N; [M+H]+; (4-methyl-6-piperidin-1-ylpyridazin-3-yl)hydrazine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.279; LBGLYAJNIDZGGO-UHFFFAOYSA-N; [M+ACN+H]+; 4-(4-methyl-1,2,4-triazol-3-yl)piperidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.275; KDHWOCLBMVSZPG-UHFFFAOYSA-N; [M+2ACN+H]+; 3-imidazol-1-ylpropan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.149; PHSPJQZRQAJPPF-UHFFFAOYSA-N; [M+2ACN+H]+; 2-(1H-imidazol-5-yl)-N-methylethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.140; OYBUININCBHVPI-UHFFFAOYSA-N; [M+ACN+H]+; 1-(1-methylimidazol-2-yl)piperazine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.000; BIQCBPGYBSLAOL-UHFFFAOYSA-N; [M+H]+; [2-(4-methylpiperazin-1-yl)pyrimidin-4-yl]methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.988; ZECYEEYVUPZUEP-UHFFFAOYSA-N; [M+H]+; 6-[2-(aminomethyl)pyrrolidin-1-yl]-N-methylpyrimidin-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.827; UQIGFNXZPGBMLH-UHFFFAOYSA-N; [M+H]+; 6-cyclopropyl-2-N,2-N,4-N,4-N-tetramethyl-1,3,5-triazine-2,4-diamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.713; UGYXPZQILZRKJJ-UHFFFAOYSA-N; [M+2ACN+H]+; 2-(5-methyl-1H-imidazol-4-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.652; XIRHPUATWAYWSH-UHFFFAOYSA-N; [M+ACN+H]+; 2-[2-[cyanomethyl(methyl)amino]ethyl-methylamino]acetonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.511; DSEMCBZVWDDRJS-UHFFFAOYSA-N; [M+ACN+H]+; N,N-dimethyl-5-(methylaminomethyl)pyrimidin-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.500; VCBYBXAUBOKBSZ-UHFFFAOYSA-N; [M+ACN+H]+; N,N-dimethyl-4-(methylaminomethyl)pyrimidin-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.497; QUTNNKVOFOZWEM-UHFFFAOYSA-N; [M+ACN+H]+; 4-(aminomethyl)-N,N,6-trimethylpyrimidin-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.488; AAVVZAZZXUMURZ-UHFFFAOYSA-N; [M+ACN+H]+; 2-(5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyridin-3-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.476; UZBROTQFSPKCTC-UHFFFAOYSA-N; [M+ACN+H]+; 1-(5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyridin-3-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.469; AYEZDNZCTPGJSA-UHFFFAOYSA-N; [M+ACN+H]+; 2-[1-(cyclopropylmethyl)triazol-4-yl]ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.443; BYVMDDKNSVCZEG-UHFFFAOYSA-N; [M+ACN+H]+; 3-(3-cyclopropyl-1H-1,2,4-triazol-5-yl)propan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.435; CPAGZVLINCPJEH-UHFFFAOYSA-N; [M+2ACN+H]+; 2-(3-methylimidazol-4-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.398; HOSVESHQDSFAST-UHFFFAOYSA-N; [M+ACN+H]+; 2-[2-(2-cyanopropan-2-yl)hydrazinyl]-2-methylpropanenitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.359; JTEUFNQZAUZEGI-UHFFFAOYSA-N; [M+ACN+H]+; 3-N,3-N,6-N,6-N-tetramethylpyridazine-3,6-diamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.327; XDKYTXBAVJELDQ-UHFFFAOYSA-N; [M+2ACN+H]+; 2-(2-methyl-1H-imidazol-5-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.313; HQNOODJDSFSURF-UHFFFAOYSA-N; [M+2ACN+H]+; 3-(1H-imidazol-2-yl)propan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.254; ZOMKCDYJHAQMCU-UHFFFAOYSA-N; [M+2ACN+H]+; 4-butyl-1,2,4-triazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.249; MBIVPEKQMUQASJ-UHFFFAOYSA-N; [M+ACN+H]+; 2-(1H-imidazol-2-yl)-1-methylpiperazine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.245; HLVMFESFZBIMBC-UHFFFAOYSA-N; [M+ACN+H]+; 3-propan-2-yl-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.173; HEWBDSWDDPJBLU-UHFFFAOYSA-N; [M+2ACN+H]+; N-methyl-1-(5-methyl-1H-pyrazol-3-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.172; BJOZTPFIJGKTJI-UHFFFAOYSA-N; [M+2ACN+H]+; N-methyl-1-(1-methylpyrazol-3-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.169; IZJQTFALMLLZQJ-UHFFFAOYSA-N; [M+2ACN+H]+; 1-(1-methylpyrazol-3-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.168; NYHQQFLQNZBQGE-UHFFFAOYSA-N; [M+2ACN+H]+; 1-(5-methyl-1H-pyrazol-3-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.168; HVJSAASIIATSGA-UHFFFAOYSA-N; [M+2ACN+H]+; 2-(1-methylpyrazol-3-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.152; PUVWFSUNHHFSFG-UHFFFAOYSA-N; [M+2ACN+H]+; N-ethyl-1-methylpyrazol-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.149; XCKQBMQJPNDJLD-UHFFFAOYSA-N; [M+2ACN+H]+; 2-(1-methylimidazol-2-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.147; RSAZAAWMBSYBFM-UHFFFAOYSA-N; [M+2ACN+H]+; N-methyl-1-(1-methylimidazol-4-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.145; YFSZWZHEKIMAJJ-UHFFFAOYSA-N; [M+2ACN+H]+; N-methyl-1-(1-methylimidazol-2-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.144; ADIMIJGUVBPQPB-UHFFFAOYSA-N; [M+2ACN+H]+; 1-(1-methylimidazol-2-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.144; VWPUDWHRYBWJRG-UHFFFAOYSA-N; [M+2ACN+H]+; N-methyl-1-(5-methyl-1H-imidazol-2-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.143; ICKXLSHRBIKQFM-UHFFFAOYSA-N; [M+2ACN+H]+; 1-(1-methylimidazol-4-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.138; CEDXNHGVYPISPG-UHFFFAOYSA-N; [M+ACN+H]+; 1-(1-methylpyrazol-4-yl)piperazine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.137; CHGIPIYKGPNYKT-UHFFFAOYSA-N; [M+2ACN+H]+; N-methyl-1-(2-methylpyrazol-3-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.135; YZCXLAHTHBVYGB-UHFFFAOYSA-N; [M+2ACN+H]+; N-methyl-1-(3-methylimidazol-4-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.133; UGBXFYZRZQPHFK-UHFFFAOYSA-N; [M+2ACN+H]+; 2-(2-methylpyrazol-3-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.132; RRQYXOXCBVYWMU-UHFFFAOYSA-N; [M+2ACN+H]+; 1-(2-methylpyrazol-3-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.130; TYHVEYPFKAWYRG-UHFFFAOYSA-N; [M+2ACN+H]+; N-methyl-1-(5-methyl-1H-pyrazol-4-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.128; ARKPMOZBRKFUHB-UHFFFAOYSA-N; [M+2ACN+H]+; 1-(3-methylimidazol-4-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.123; VIUKMNKXXJAZLD-UHFFFAOYSA-N; [M+ACN+H]+; 5-piperidin-4-yl-1H-pyrazol-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.101; LXSAPEUXYKTICH-UHFFFAOYSA-N; [M+ACN+H]+; 1-cyclohexyl-5-methyltetrazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.097; SJAACDLJWHJJFO-UHFFFAOYSA-N; [M+2ACN+H]+; 1-(1H-imidazol-2-yl)-N,N-dimethylmethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.097; FJEIRKHYFRMBAB-UHFFFAOYSA-N; [M+ACN+H]+; 3-(4-methyl-1,2,4-triazol-3-yl)piperidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.097; KIPVVJYELYMMQA-UHFFFAOYSA-N; [M+2ACN+H]+; 1-(1-methylpyrazol-4-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.094; LEHGOSZFUSOULZ-UHFFFAOYSA-N; [M+2ACN+H]+; N-methyl-1-(1-methylpyrazol-4-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.092; VVIZVEAXGCWHOM-UHFFFAOYSA-N; [M+2ACN+H]+; 2-(1-methylpyrazol-4-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.086; IRPFSJQQONMYDX-UHFFFAOYSA-N; [M+ACN+H]+; 4-(triazol-1-ylmethyl)piperidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.085; JSXVMXHCFBPCLV-UHFFFAOYSA-N; [M+2ACN+H]+; 3-pyrazol-1-ylpropan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.084; UWVUXGHAXNILPG-UHFFFAOYSA-N; [M+2ACN+H]+; 1-pyrazol-1-ylpropan-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.083; OAMZBBRGCCAGJL-UHFFFAOYSA-N; [M+ACN+H]+; 4-(1H-1,2,4-triazol-5-yl)cyclohexan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.082; UUHRZOGUDROUKQ-UHFFFAOYSA-N; [M+2ACN+H]+; 2-imidazol-1-yl-N-methylethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.080; HADFJARZQWSNHR-UHFFFAOYSA-N; [M+ACN+H]+; 1-cyclohexyl-1,2,4-triazol-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.078; CUZNBROTVLFZKQ-UHFFFAOYSA-N; [M+2ACN+H]+; N-methyl-2-pyrazol-1-ylethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.076; VMPRGXHRBMHXOH-UHFFFAOYSA-N; [M+ACN+H]+; 4-(5-methyltriazol-1-yl)piperidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.070; OIJPPRAITGSIRG-UHFFFAOYSA-N; [M+ACN+H]+; 3-(1,2,4-triazol-1-ylmethyl)piperidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.056; AHGXYHGWKDLIPH-UHFFFAOYSA-N; [M+ACN+H]+; 4-(triazol-1-yl)azepane
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.056; ZLGCTFLARAWVND-UHFFFAOYSA-N; [M+ACN+H]+; 4-(1,2,4-triazol-1-ylmethyl)piperidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.054; DVYSYRXOUIBQJG-UHFFFAOYSA-N; [M+ACN+H]+; 4-(5-methyl-1H-1,2,4-triazol-3-yl)piperidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.048; HZOIHLSZMGDITC-UHFFFAOYSA-N; [M+2ACN+H]+; 3-(1H-pyrazol-5-yl)propan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.047; IHDFTEVCMVTMSP-UHFFFAOYSA-N; [M+2ACN+H]+; 3-(1H-imidazol-5-yl)propan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.044; LLWRMGZNTZIBOV-UHFFFAOYSA-N; [M+ACN+H]+; 2-(1-methylpyrazol-4-yl)piperazine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.040; VAWCWWMADSCPDU-UHFFFAOYSA-N; [M+ACN+H]+; 4-(triazol-1-yl)cyclohexan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.037; WQYVPLKUHYMUJI-UHFFFAOYSA-N; [M+ACN+H]+; 2-(triazol-1-ylmethyl)piperidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.037; RYHAXZZMCHTQKU-UHFFFAOYSA-N; [M+ACN+H]+; 2-(1,2,4-triazol-1-ylmethyl)piperidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.037; YLICHTZAMDDIIM-UHFFFAOYSA-N; [M+ACN+H]+; 2-(4-methyl-1,2,4-triazol-3-yl)piperidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.032; VCZQHTMMBHUSEO-UHFFFAOYSA-N; [M+ACN+H]+; (3-methyl-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyridin-6-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.028; PJYAFOPPECXXAT-UHFFFAOYSA-N; [M+ACN+H]+; 2-ethyl-5,6,7,8-tetrahydro-[1,2,4]triazolo[1,5-a]pyridin-6-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.028; MEWCPBOFWYJTNM-UHFFFAOYSA-N; [M+ACN+H]+; 1-(5-methyl-1H-pyrazol-3-yl)piperazine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.027; ZRRJOIZUONRZAO-UHFFFAOYSA-N; [M+2ACN+H]+; N,N-dimethyl-1-(1H-pyrazol-4-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.021; VMLRMVKKLVMTPX-UHFFFAOYSA-N; [M+ACN+H]+; 3-methyl-3-(1H-1,2,4-triazol-5-yl)piperidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.016; HWMQIGXDBKSZNN-UHFFFAOYSA-N; [M+ACN+H]+; 1-(1-methylpyrazol-3-yl)pyrrolidin-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.015; NKPUYKJNDVFPCP-UHFFFAOYSA-N; [M+2ACN+H]+; 3-(1H-pyrazol-4-yl)propan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.005; CJEYOZIHKHZSIM-UHFFFAOYSA-N; [M+ACN+H]+; 3,5-dimethyl-1-pyrrolidin-3-yl-1,2,4-triazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.003; BJHXFXZRIMEDER-UHFFFAOYSA-N; [M+2ACN+H]+; 1-(1H-pyrazol-4-yl)propan-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.002; KAIJJBGBXLAITA-UHFFFAOYSA-N; [M+ACN+H]+; 1,3-dimethyl-4,5,6,7-tetrahydropyrazolo[3,4-b]pyridin-5-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.001; QKVROWZQJVDFSO-UHFFFAOYSA-N; [M+2ACN+H]+; 2-(2-methylimidazol-1-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.991; NHOCIKGCQZOHNI-UHFFFAOYSA-N; [M+ACN+H]+; 5-cyclohexyl-1-methyltetrazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.980; PGYXLTZSSAXNND-UHFFFAOYSA-N; [M+ACN+H]+; 1-(2-pyrrolidin-1-ylethyl)-1,2,4-triazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.979; IACZAGXWNRNOBU-UHFFFAOYSA-N; [M+ACN+H]+; 6,7,8,9-tetrahydro-5H-[1,2,4]triazolo[4,3-a]azepin-3-ylmethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.977; NOOUZWQNFVDCFF-UHFFFAOYSA-N; [M+ACN+H]+; 3-azido-9-azabicyclo[3.3.1]nonane
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.949; NCMDCWBSYIDNHM-UHFFFAOYSA-N; [M+2ACN+H]+; 2-(4-methylpyrazol-1-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.929; SSDGMKHZMNTWLS-UHFFFAOYSA-N; [M+2ACN+H]+; 1,3,5-trimethylpyrazol-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.795; KPWCURLGTSCHNE-UHFFFAOYSA-N; [M+2ACN+H]+; 5-ethyl-4-methyl-1H-pyrazol-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.764; UGERGYDWQOPISO-UHFFFAOYSA-N; [M+2ACN+H]+; 3,5-diethyl-1H-1,2,4-triazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.752; OEXNVHXUPNHOPP-UHFFFAOYSA-N; [M+2ACN+H]+; 1-propan-2-ylpyrazol-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.748; BDOQDYNVOVZWSL-UHFFFAOYSA-N; [M+2ACN+H]+; 4-ethyl-5-methyl-1H-imidazol-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.736; AHRQLLLOCPXPCS-UHFFFAOYSA-N; [M+2ACN+H]+; 2-propan-2-ylpyrazol-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.735; JGYXJOBBROGMLL-UHFFFAOYSA-N; [M+2ACN+H]+; (1,5-dimethylpyrazol-3-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.734; YMMVIBHFGRZKPK-UHFFFAOYSA-N; [M+2ACN+H]+; (1,5-dimethylpyrazol-4-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.731; WBEDVSWPSZQPQZ-UHFFFAOYSA-N; [M+2ACN+H]+; 1-ethyl-3-methylpyrazol-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.727; MIAQYVFWXDEYAK-UHFFFAOYSA-N; [M+2ACN+H]+; (1-ethylpyrazol-4-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.723; LLUVLTBWVXCDQN-UHFFFAOYSA-N; [M+2ACN+H]+; (1-ethylpyrazol-3-yl)methanamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -63.510; RHRVANRKEISTIR; [M+C2H3N+H]+; 4,10-dinitrile
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -82.643; XIRHPUATWAYWSH; [M+C2H3N+H]+; (N,N''-Dimethylethylenedinitrilo)diacetonitrile
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -91.542; KDHWOCLBMVSZPG; [M+C4H6N2+H]+; QuadraPure&reg; IMDAZ
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -97.860; CPAGZVLINCPJEH; [M+C4H6N2+H]+; 3-Methylhistamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -104.290; QKVROWZQJVDFSO; [M+C4H6N2+H]+; ACMC-20dure
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -106.268; FHQDWPCFSJMNCT; [M+C4H6N2+H]+; Lopac-M-4910
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -107.351; ZOMKCDYJHAQMCU; [M+C4H6N2+H]+; Butrizol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -118.168; UQIGFNXZPGBMLH; [M+H]+; 2,4-Bis(dimethylamino)-6-cyclopropyl-s-triazine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -119.541; PHSPJQZRQAJPPF; [M+C4H6N2+H]+; Tocris-0573
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -119.892; YFSZWZHEKIMAJJ; [M+C4H6N2+H]+; Ambcb4101396
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -125.293; CHGIPIYKGPNYKT; [M+C4H6N2+H]+; 1-methyl-5-[(methylamino)methyl]pyrazole
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -128.017; PGYXLTZSSAXNND; [M+C2H3N+H]+; 1-(2-pyrrolidin-1-ylethyl)-1,2,4-triazole
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -130.194; ZLGCTFLARAWVND; [M+C2H3N+H]+; 4-(1H-1,2,4-triazol-1-ylmethyl)piperidine dihydrochloride
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -132.470; LLUVLTBWVXCDQN; [M+C4H6N2+H]+; (1-ethylpyrazol-3-yl)methanamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -134.415; BJOZTPFIJGKTJI; [M+C4H6N2+H]+; methyl[(1-methylpyrazol-3-yl)methyl]amine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -135.129; RRQYXOXCBVYWMU; [M+C4H6N2+H]+; 1-(1-methylpyrazol-5-yl)ethylamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -138.138; XIIAZKSXQSTSEQ; [M+C4H6N2+H]+; 1-ethyl-5-methylpyrazole-4-ylamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -143.036; XDKYTXBAVJELDQ; [M+C4H6N2+H]+; 2-Methylhistamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -145.206; IHDFTEVCMVTMSP; [M+C4H6N2+H]+; Homohistamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -146.272; JSXVMXHCFBPCLV; [M+C4H6N2+H]+; 3-pyrazolylpropylamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -148.697; CUZNBROTVLFZKQ; [M+C4H6N2+H]+; N-methyl-2-pyrazol-1-ylethanamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -149.826; DAOWQCXPMWGSBW; [M+C4H6N2+H]+; 5-aminomethyl-1,3-dimethylpyrazole
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -150.159; PUVWFSUNHHFSFG; [M+C4H6N2+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -155.006; NCMDCWBSYIDNHM; [M+C4H6N2+H]+; 2-(4-methylpyrazolyl)ethylamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -155.103; IZJQTFALMLLZQJ; [M+C4H6N2+H]+; 1-(1-methylpyrazol-3-yl)ethanamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -159.538; JGYXJOBBROGMLL; [M+C4H6N2+H]+; (1,5-dimethylpyrazol-3-yl)methanamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -159.819; MIAQYVFWXDEYAK; [M+C4H6N2+H]+; (1-ethylpyrazol-4-yl)methanamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -160.850; MAGGRXZKFUAOGD; [M+C4H6N2+H]+; 1-ethyl-5-methylpyrazol-3-amine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -165.467; LLWRMGZNTZIBOV; [M+C2H3N+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -165.843; TZLVUWBGUNVFES; [M+C4H6N2+H]+; ethylmethylpyrazolamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -169.787; LEHGOSZFUSOULZ; [M+C4H6N2+H]+; N-Methyl-1-(1-methyl-1H-pyrazol-4-yl)
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -170.516; QVNYNCBHNRXHTB; [M+C4H6N2+H]+; 3-ethyl-1-methyl-1H-pyrazol-5-amine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -182.310; XNQIOISZPFVUFG; [M+C4H6N2+H]+; Tocris-0569
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -185.168; UGYXPZQILZRKJJ; [M+C4H6N2+H]+; 4-Methylhistamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -192.824; SSDGMKHZMNTWLS; [M+C4H6N2+H]+; trimethylpyrazol-4-amine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -205.744; XHWLCRAUUAFQTD; [M+C4H6N2+H]+; Ambcb4014354
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -206.381; HOSVESHQDSFAST; [M+C2H3N+H]+; Hydrazodiisobutyronitrile
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -207.079; VIUKMNKXXJAZLD; [M+C2H3N+H]+; 3-piperidin-4-yl-1H-pyrazol-5-amine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -209.302; AHRQLLLOCPXPCS; [M+C4H6N2+H]+; 2-isopropylpyrazol-3-amine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -212.421; MECWXEINLHIGIW; [M+C4H6N2+H]+; 1-isopropylpyrazol-3-amine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -220.084; NKPUYKJNDVFPCP; [M+C4H6N2+H]+; 1H-Pyrazole-4-propanamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -223.381; QBUQWOXNOUFIGB; [M+C4H6N2+H]+; (3-ethyl-1H-pyrazol-5-yl)methanamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -223.621; NHOCIKGCQZOHNI; [M+C2H3N+H]+; 5-cyclohexyl-1-methyltetrazole
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -230.708; LXSAPEUXYKTICH; [M+C2H3N+H]+; 1-cyclohexyl-5-methyltetrazole
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -242.874; NBWAZUNSLABYAM; [M+C4H6N2+H]+; 1-Aza-2,7-diiminocycloheptane
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -258.726; UQTLFNBARWAWIS; [M+C4H6N2+H]+; 4-isopropyl-1H-pyrazol-5-amine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -259.812; INSBBZDRQQVATI; [M+C4H6N2+H]+; 3-Isopropyl-1H-pyrazol-5-amine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -271.414; JTEUFNQZAUZEGI; [M+C2H3N+H]+; 3,6-Bis(dimethylamino)pyridazine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -282.066; DGCMIDYTTCDSBB; [M+C2H3N+H]+; 2-N,3-N,4-N-trimethylpyridine-2,3,4-triamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.442; RHRVANRKEISTIR; [M+C2H3N+H]+; 4,10-dinitrile
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.328; KDHWOCLBMVSZPG; [M+C4H6N2+H]+; QuadraPure&reg; IMDAZ
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.159; UQIGFNXZPGBMLH; [M+H]+; 2,4-Bis(dimethylamino)-6-cyclopropyl-s-triazine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -51.605; QKVROWZQJVDFSO; [M+C4H6N2+H]+; 2-(2-methyl-1H-imidazol-1-yl)ethanamine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -54.052; UUHRZOGUDROUKQ; [M+C4H6N2+H]+; 2-(1H-imidazol-3-ium-3-yl)-N-methylethanamine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -55.597; HQNOODJDSFSURF; [M+C4H6N2+H]+; 3-(1H-Imidazol-2-YL)propan-1-amine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -58.350; KDHWOCLBMVSZPG; [M+C4H6N2+H]+; 3-(1H-imidazol-1-ium-1-yl)propan-1-amine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -63.355; XAKAVKFLXVMKJT; [M+C4H6N2+H]+; (1-ethyl-1H-imidazol-2-yl)methanamine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -77.640; ZOMKCDYJHAQMCU; [M+C4H6N2+H]+; 4-butyl-1H-1,2,4-triazol-4-ium
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -78.319; IHDFTEVCMVTMSP; [M+C4H6N2+H]+; 1H-Imidazole-4-propanamine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -78.579; RHRVANRKEISTIR; [M+C2H3N+H]+; Propanenitrile, 3,3'-(1,2-ethanediyldiimino)bis-
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -81.749; YFSZWZHEKIMAJJ; [M+C4H6N2+H]+; N-methyl-1-(1-methyl-1H-imidazol-2-yl)methanamine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -84.533; JMVGTUJLDTZQFC; [M+C4H6N2+H]+; (1-ethyl-1H-imidazol-5-yl)methanamine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -84.633; NCMDCWBSYIDNHM; [M+C4H6N2+H]+; 2-(4-methyl-1H-pyrazol-1-yl)ethanamine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -101.788; UQIGFNXZPGBMLH; [M+H]+; s-Triazine, 2,4-bis(dimethylamino)-6-cyclopropyl-
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -109.220; JTEUFNQZAUZEGI; [M+C2H3N+H]+; 3,6-Bis(dimethylamino)pyridazine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -115.195; HOSVESHQDSFAST; [M+C2H3N+H]+; Hydrazodiisobutyronitrile
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -117.123; PGYXLTZSSAXNND; [M+C2H3N+H]+; 1-(2-Pyrrolidinylethyl)-1H-1,2,4-triazole
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -125.457; XIRHPUATWAYWSH; [M+C2H3N+H]+; N,N'-Dicyanomethyl-N,N'-dimethylethylenediamine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -137.760; CEDXNHGVYPISPG; [M+C2H3N+H]+; 1-(1-methyl-1H-pyrazol-4-yl)piperazine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -142.926; VCZQHTMMBHUSEO; [M+C2H3N+H]+; [(6S)-3-methyl-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyridin-6-yl]methanamine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -143.521; IACZAGXWNRNOBU; [M+C2H3N+H]+; 1-(6,7,8,9-tetrahydro-5H-[1,2,4]triazolo[4,3-a]azepin-3-yl)methanamine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -159.000; LLWRMGZNTZIBOV; [M+C2H3N+H]+; 2-(1-methyl-1H-pyrazol-4-yl)piperazine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -164.092; MBIVPEKQMUQASJ; [M+C2H3N+H]+; (2R)-2-(1H-imidazol-2-yl)-1-methylpiperazine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -193.743; QSERFXPZIOTLLW; [M+H]+; N,N-dimethyl-4-(piperazin-1-yl)pyrimidin-2-amine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -223.212; WOSMHMANFDUDQJ; [M+H]+; N4-methyl-6-piperidin-1-yl-pyrimidine-2,4-diamine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -299.834; ZECYEEYVUPZUEP; [M+H]+; 6-[2-(aminomethyl)pyrrolidin-1-yl]-N-methylpyrimidin-4-amine
COMMENT: PROPOSED_COMPOUND SIRIUS6_Confidence:biodatabase 0.289; UQIGFNXZPGBMLH; [M+H]+; s-Triazine, 2,4-bis(dimethylamino)-6-cyclopropyl-
COMMENT: PROPOSED_COMPOUND SIRIUS6_Confidence:biodatabase 0.270; QKVROWZQJVDFSO; [M+C4H6N2+H]+; 2-(2-methyl-1H-imidazol-1-yl)ethanamine
COMMENT: PROPOSED_COMPOUND SIRIUS6_Confidence:biodatabase 0.242; RHRVANRKEISTIR; [M+C2H3N+H]+; Propanenitrile, 3,3'-(1,2-ethanediyldiimino)bis-
COMMENT: CONFIDENCE Level 5: Exact mass of interest 208.155688; Observed in MS1; Charge state Unknown;
CH$NAME: Uncharacterized
CH$COMPOUND_CLASS: Uncharacterized
CH$FORMULA: C39H42O2
CH$EXACT_MASS: 542.318480
CH$SMILES: CCCC#Cc1cc(C#CCCC)cc(C#Cc2cc(C#CC(C)(C)C)c(cc2C#CC(C)(C)C)C2OCCO2)c1
CH$IUPAC: InChI=1S/C39H42O2/c1-9-11-13-15-30-25-31(16-14-12-10-2)27-32(26-30)17-18-33-28-35(20-22-39(6,7)8)36(37-40-23-24-41-37)29-34(33)19-21-38(3,4)5/h25-29,37H,9-12,23-24H2,1-8H3
CH$LINK: PUBCHEM CID:11353257
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Serum
AC$INSTRUMENT: Nexera X2 UHPLC system, Shimadzu - Q Exactive Orbitrap, Thermo Scientific
AC$INSTRUMENT_TYPE: LC-ESI-QFT
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE POSITIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY 20 V
AC$MASS_SPECTROMETRY: COLLISION_GAS N2
AC$MASS_SPECTROMETRY: FRAGMENTATION_MODE CID
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE 4.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 0.75; MS2(ppm) 4.00
AC$CHROMATOGRAPHY: COLUMN_NAME GL-HilicAex 2.1 x 150 mm, 5 mm (Resonac)
AC$CHROMATOGRAPHY: FLOW_GRADIENT B conc(%). 0 min: 95, 0.5 min: 95, 15.5 min: 40, 16.5 min: 0, 26.5 min: 0, 27.5 min: 95, 35 min: 95.
AC$CHROMATOGRAPHY: FLOW_RATE 0.4 mL/min
AC$CHROMATOGRAPHY: RETENTION_TIME 3.128
MS$FOCUSED_ION: PRECURSOR_M/Z 208.155688
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-0a4i-0290000000-d95e9fec0a398a33b1d3
PK$ANNOTATION: m/z int annotation m/z_nocal m/z_std(ppm) int_std cor n
  69.0446322 22.6106 ? 69.045258 1.5787 6.88 0.0611 27
  71.0602994 19.7115 ? 71.060913 1.4213 4.80 0.4768 27
  87.0916269 25.1665 ? 87.092080 1.7797 5.38 0.4563 30
  97.0759974 27.9695 ? 97.076342 1.3907 5.77 0.4182 29
  112.0867154 20.5565 ? 112.086920 2.7657 4.25 0.2461 24
  122.0712414 28.2548 ? 122.071324 1.8760 7.01 0.3166 30
  138.1025445 40.5073 ? 138.102450 1.7451 8.20 0.4948 31
  140.0455427 21.1950 ? 140.045447 2.2207 6.39 -0.1779 23
  140.0818257 84.5211 ? 140.081730 1.0280 10.84 0.2230 31
  140.1181858 37.4005 ? 140.118090 1.7271 8.11 0.5633 31
  163.0978389 29.9669 ? 163.097728 2.0479 6.48 0.4576 30
  165.1135119 48.4302 ? 165.113400 1.5565 8.96 0.4085 31
  167.0927631 26.0926 ? 167.092650 2.1066 6.97 -0.0695 29
  191.1289756 25.8834 ? 191.128847 2.8776 7.34 0.0202 26
  208.0834606 86.9096 ? 208.083322 2.9940 16.32 0.2338 30
  208.1218569 145.9918 ? 208.121718 4.6223 27.77 -0.2392 25
  208.1557790 999.0000 ? 208.155640 0.3267 0.00 1.0000 31
PK$NUM_PEAK: 17
PK$PEAK: m/z int. rel.int.
  69.044632 22.61 22
  71.060299 19.71 19
  87.091627 25.17 25
  97.075997 27.97 27
  112.086715 20.56 20
  122.071241 28.25 28
  138.102544 40.51 40
  140.045543 21.20 21
  140.081826 84.52 84
  140.118186 37.40 37
  163.097839 29.97 29
  165.113512 48.43 48
  167.092763 26.09 26
  191.128976 25.88 25
  208.083461 86.91 86
  208.121857 145.99 145
  208.155779 999.00 999
//
